CrossrefInfokarte
Real-world cohort study of PD-1 blockade plus lenvatinib for advanced intrahepatic cholangiocarcinoma: effectiveness, safety, and biomarker analysis
Cancer Immunology, Immunotherapy · 2023-11 · 72 (11) · 3717-3726
DOI: 10.1007/s00262-023-03523-2 ↗Abstract
Kein Abstract verfügbar.
EUVIMED